CO6821891A2 - Methods to treat or prevent cholesterol-related disorders - Google Patents

Methods to treat or prevent cholesterol-related disorders

Info

Publication number
CO6821891A2
CO6821891A2 CO13286712A CO13286712A CO6821891A2 CO 6821891 A2 CO6821891 A2 CO 6821891A2 CO 13286712 A CO13286712 A CO 13286712A CO 13286712 A CO13286712 A CO 13286712A CO 6821891 A2 CO6821891 A2 CO 6821891A2
Authority
CO
Colombia
Prior art keywords
treat
methods
related disorders
prevent cholesterol
cholesterol
Prior art date
Application number
CO13286712A
Other languages
Spanish (es)
Inventor
Joyce Chi Yee Chan
John O Gibbs
Clapton S Dias
Scott Wasserman
Robert Andrew Donald Scott
Christi L Glogston
Timothy Osslund
Evan A Stein
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CO6821891A2 publication Critical patent/CO6821891A2/en

Links

CO13286712A 2011-05-10 2013-12-06 Methods to treat or prevent cholesterol-related disorders CO6821891A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161484610P 2011-05-10 2011-05-10
US201161562303P 2011-11-21 2011-11-21
US201261595526P 2012-02-06 2012-02-06
US201261614417P 2012-03-22 2012-03-22

Publications (1)

Publication Number Publication Date
CO6821891A2 true CO6821891A2 (en) 2013-12-31

Family

ID=50071964

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13286712A CO6821891A2 (en) 2011-05-10 2013-12-06 Methods to treat or prevent cholesterol-related disorders

Country Status (1)

Country Link
CO (1) CO6821891A2 (en)

Similar Documents

Publication Publication Date Title
CR20140151A (en) PIPERIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES-1-ARILCARBOLINO-4-OXYA
BR112014006324A2 (en) method to treat hcv
CL2015001157A1 (en) Compositions and methods to treat proteinopathies.
BR112014018857A2 (en) nut
CO6791602A2 (en) Methods and systems for the treatment of wells
CO6811862A2 (en) Methods to treat multiple sclerosis and preserve and / or increase myelin content
BR112013033720A2 (en) method to treat eczema
CO6821964A2 (en) Compounds for the treatment of addiction
BR112013033944A2 (en) synergistic combination
BR112014006702A2 (en) method to treat osteoporosis
BR112013033974A2 (en) combination therapy
DK2760886T3 (en) Immunocytokin combination therapy
DK3395357T3 (en) COMPOSITION FOR CONTROLLED OVARI STIMULATION
BR112014009785A2 (en) method to treat or reduce efp
FI20115876A0 (en) Combination therapy
DK2697074T3 (en) SAFETY ACT
BR112013025299A2 (en) anchor set
DK2903896T3 (en) Course Facilities
BR112013008528A2 (en) Methods To Treat Psoriasis
CO6880064A2 (en) Therapeutic methods
BR112015015258A2 (en) Methods to Treat Gastrointestinal Tract Disorders
CO6821965A2 (en) Deuterated 1-piperazino-3-phenyl-indanes for the treatment of schizophrenia
DK3351554T3 (en) GLUTEN-RELATED DISORDERS
FI20115640A0 (en) combination therapy
FI20115288L (en) I crushed

Legal Events

Date Code Title Description
FG Application granted